Home Compliance Silver Linings for FY16: DOJ FCA Stats Tough on Pharma and Banks,... ComplianceExpert OpinionNews Silver Linings for FY16: DOJ FCA Stats Tough on Pharma and Banks, but Defense Pipeline Narrowing December 20, 2016 7 Share FacebookLinkedinTwitter You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Gag Orders Are Still Hampering Federal Whistleblowers, Agency Warns Compliance Treasury Department Moves to Enhance CFIUS’s Enforcement Authorities Compliance FCPA Questions To Ponder